These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8994333)

  • 21. Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C.
    Hamada H; Yatsuhashi H; Yano K; Daikoku M; Arisawa K; Inoue O; Koga M; Nakata K; Eguchi K; Yano M
    Cancer; 2002 Jul; 95(2):331-9. PubMed ID: 12124834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterosexual transmission of hepatitis C in Italy.
    Mele A; Stroffolini T; Tosti ME; Corona R; Santonastasi F; Gallo G; Ragni P; Balocchini E; Bernacchia R; Moiraghi A
    J Med Virol; 1999 Feb; 57(2):111-3. PubMed ID: 9892393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case-control study on the risk factors of hepatitis C virus infection among Koreans.
    Kim YS; Ahn YO; Kim DW
    J Korean Med Sci; 1996 Feb; 11(1):38-43. PubMed ID: 8703369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing.
    Corson S; Greenhalgh D; Taylor A; Palmateer N; Goldberg D; Hutchinson S
    Drug Alcohol Depend; 2013 Nov; 133(1):172-9. PubMed ID: 23791029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of tattooing and hepatitis C virus infection: a multicenter case-control study.
    Carney K; Dhalla S; Aytaman A; Tenner CT; Francois F
    Hepatology; 2013 Jun; 57(6):2117-23. PubMed ID: 23315899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS).
    Murphy EL; Bryzman SM; Glynn SA; Ameti DI; Thomson RA; Williams AE; Nass CC; Ownby HE; Schreiber GB; Kong F; Neal KR; Nemo GJ
    Hepatology; 2000 Mar; 31(3):756-62. PubMed ID: 10706569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection.
    Karmochkine M; Carrat F; Dos Santos O; Cacoub P; Raguin G
    J Viral Hepat; 2006 Nov; 13(11):775-82. PubMed ID: 17052278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sexual activity as a risk factor for hepatitis C in Puerto Rico.
    De Jesús-Caraballo J; Toro DH; Rodríguez-Pérez F; Ruiz H; Dueño MI; Alvarez M; Suárez-Pérez E;
    Bol Asoc Med P R; 2008; 100(3):15-20. PubMed ID: 19227710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of hepatitis C virus infection in a southern Italian rural region. Clinical aspects and evidence of inapparent parenteral exposure.
    Cecere A; Marotta F; Lucariello A; Tancredi L; Vangieri B; Gattoni A
    Panminerva Med; 2003 Dec; 45(4):253-9. PubMed ID: 15206166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus.
    Roudot-Thoraval F; Bastie A; Pawlotsky JM; Dhumeaux D
    Hepatology; 1997 Aug; 26(2):485-90. PubMed ID: 9252163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis.
    Gordon SC; Kodali VP; Silverman AL; Dmuchowski CF; Urdea MS; Chan CS; Wilber JC
    Am J Gastroenterol; 1994 Sep; 89(9):1458-61. PubMed ID: 8079919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations.
    Wang J; Liu J; Huang Y; Wright DJ; Li J; Zhou Z; He W; Yang T; Yao F; Zhu X; Wen G; Bi X; Tiemuer MH; Wen X; Huang M; Cao R; Yun Z; Lü Y; Ma H; Guo N; Yu Q; Ness P; Shan H;
    Transfusion; 2013 Oct; 53(10 Pt 2):2489-97. PubMed ID: 23781978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk factors for hepatitis C among injecting drug users in Oslo].
    Dalgard O; Egeland A; Ervik R; Vilimas K; Skaug K; Steen TW
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):101-4. PubMed ID: 19151801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C seroprevalence and correlation between viral load and viral genotype among primary care clients in Mexico.
    Burguete-García AI; Conde-González CJ; Jiménez-Méndez R; Juárez-Díaz Y; Meda-Monzón E; Torres-Poveda K; Madrid-Marina V
    Salud Publica Mex; 2011; 53 Suppl 1():S7-12. PubMed ID: 21877076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study.
    Mirmomen S; Alavian SM; Hajarizadeh B; Kafaee J; Yektaparast B; Zahedi MJ; Zand V; Azami AA; Hosseini MM; Faridi AR; Davari K; Hajibeigi B
    Arch Iran Med; 2006 Oct; 9(4):319-23. PubMed ID: 17061602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A higher than expected recovery rate from hepatitis C infection amongst adolescents: a community study in a hepatitis C-endemic township in Taiwan.
    Lee PL; Wang JH; Tung HD; Lee CM; Lu SN
    Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):367-72. PubMed ID: 15099993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of hepatitis C virus and associated risk behaviours: a population-based study in San Juan, Puerto Rico.
    Pérez CM; Suárez E; Torres EA; Román K; Colón V
    Int J Epidemiol; 2005 Jun; 34(3):593-9. PubMed ID: 15802378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatitis C: epidemiology and therapy--with special reference to long-term prognosis after IFN therapy].
    Fujiyama S; Tanaka M
    Rinsho Byori; 2000 Jan; 48(1):5-13. PubMed ID: 10756668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of B/C virus infection hepatitis in the Northern Moldavian correctional facilities risk factors.
    Bacusca AI; Coman AE; Felea D; Petrovanu R; Ioan B
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):463-70. PubMed ID: 25076716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.